Cytokeratin 7 in oropharyngeal squamous cell carcinoma: A junctional biomarker for human papillomavirus-related tumors

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 5, 2017, Pages 702-710

  Woods, Robbie S R ^a,b,c,d   Keegan, Helen ^b,d   White, Christine ^b,d   Tewari, Prerna ^b,d   Toner, Mary ^a,b   Kennedy, Susan ^c   O'Regan, Esther M ^a,b   Martin, Cara M ^b,d   Timon, Conrad V I ^a,b,c   O'Leary, John J ^a,b,d  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

^d CERVIVA Research Consortium   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOKERATIN 7; MESSENGER RNA; PROTEIN P16; TUMOR MARKER;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NONHUMAN; OROPHARYNX SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TONSIL; TONSIL TUMOR; WART VIRUS; AGED; BIOSYNTHESIS; COMPLICATION; HEAD AND NECK TUMOR; MIDDLE AGED; OROPHARYNX TUMOR; PAPILLOMAVIRUS INFECTION; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATIN-7; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 85019183017     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0619     Document Type: Article

References (68)

1. Woods RSR, O'Regan EM, Kennedy S, Martin C, O'Leary JJ, Timon C. Role of human papillomavirus in oropharyngeal squamous cell carcinoma: a review. World J Clin Cases 2014;2:172-93.
2. Begum S, Cao D, GillisonM, ZahurakM, Westra WH. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005;11:5694-9.
3. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
4. Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer 2014;14:395-405.
5. Herfs M, Vargas SO, Yamamoto Y, Howitt BE, Nucci MR, Hornick JL, et al. A novel blueprint for 'top down' differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J Pathol 2013;229:460-8.
6. Herfs M, Parra-Herran C, Howitt BE, Laury AR, Nucci MR, Feldman S, et al. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions. Am J Surg Pathol 2013;37:1311-8.
7. Herfs M, Yamamoto Y, Laury A, Wang X, Nucci MR, McLaughlin-Drubin ME, et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A 2012;109:10516-21.
8. Williams GR, Talbot IC, Northover JM, Leigh IM. Keratin expression in the normal anal canal. Histopathology 1995;26:39-44.
9. Ramalingam P, Hart WR, Goldblum JR. Cytokeratin subset immunostaining in rectal adenocarcinoma and normal anal glands. Arch Pathol LabMed 2001;125:1074-7.
10. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
11. Quinlan RA, Schiller DL, Hatzfeld M, Achtstatter T, Moll R, Jorcano JL, et al. Patterns of expression and organization of cytokeratin intermediate filaments. Ann N Y Acad Sci 1985;455:282-306.
12. Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest 1985;52:243-56.
13. Hosoya A, Kwak S, Kim EJ, Lunny DP, Lane EB, Cho SW, et al. Immunohistochemical localization of cytokeratins in the junctional region of ectoderm and endoderm. Anat Rec (Hoboken) 2010;293:1864-72.
14. Fritsch H, Zehm S, Illig R, Moser P, Aigner F. New insights into the development and differentiation of the human anorectal epithelia. Are there clinical consequences? Int J Colorectal Dis 2010;25:1231-42.
15. Wang X, Ouyang H, Yamamoto Y, Kumar PA, Wei TS, Dagher R, et al. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011;145:1023-35.
16. Favia G, Kanduc D, Lo Muzio L, Lucchese A, Serpico R. Possible association between HPV16 E7 protein level and cytokeratin 19. Int J Cancer 2004;111:795-7.
17. Kanduc D. Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alpha(1)-globin and human cytokeratin 7. J Virol 2002;76:7040-8.
18. Merkley MA, Hildebrandt E, Podolsky RH, Arnouk H, Ferris DG, Dynan WS, et al. Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes. Proteome Sci 2009;7:29.
19. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-72.
20. Jung AC, Briolat J, Millon R, de Reynies A, Rickman D, Thomas E, et al. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer 2010;126:1882-94.
21. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, et al. Novel short-fragment PCR assay for highly sensitive broadspectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-9.
22. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-17.
23. Jordan RC, LingenMW, Perez-Ordonez B, He X, Pickard R, Koluder M, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol 2012;36:945-54.
24. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294-301.
25. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2013;35:747-55.
26. Combes JD, Chen AA, Franceschi S. Prevalence of human papillomavirus in cancer of the oropharynx by gender. Cancer Epidemiol Biomarkers Prev 2014;23:2954-8.
27. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-75.
28. Mehanna H, Franklin N, Compton N, Robinson M, Powell N, Biswas-Baldwin N, et al. Geographic variation in human papillomavirus-related oropharyngeal cancer: data from four multinational randomized trials. Head Neck 2016;38 Suppl 1:E1863-9.
29. Morbini P, Capello GL, Alberizzi P, Benazzo M, Paglino C, Comoli P, et al. Markers of squamocolumnar junction cells in normal tonsils and oropharyngeal cancer with and without HPV infection. HistolHistopathol 2015;30:833-9.
30. Chow LT, Broker TR, Steinberg BM. The natural history of human papillomavirus infections of the mucosal epithelia. APMIS 2010;118:422-49.
31. Pim D, Banks L. Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs. low-risk human papillomaviruses. APMIS 2010;118:471-93.
32. Jabbar S, Strati K, Shin MK, Pitot HC, Lambert PF. Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice. Virology 2010;407:60-7.
33. Jabbar SF, Park S, Schweizer J, Berard-Bergery M, Pitot HC, Lee D, et al. Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein. Cancer Res 2012;72:4008-16.
34. Eckert RL, Crish JF, Robinson NA. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 1997;77:397-424.
35. Ross J. mRNA stability in mammalian cells. Microbiol Rev 1995;59: 423-50.
36. Brembeck FH, Moffett J, Wang TC, Rustgi AK. The keratin 19 promoter is potent for cell-specific targeting of genes in transgenic mice. Gastroenterology 2001;120:1720-8.
37. Santoro A, Pannone G, Ninivaggi R, Petruzzi M, Santarelli A, Russo GM, et al. Relationship between CK19 expression, deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma. Infect Agent Cancer 2015;10:46.
38. Alkotyfan K, Wiegand S, Muller HH, Windfuhr JP, Werner JA, Sesterhenn AM. Cyfra 21-1 as a tumor marker for follow-up of patients with squamous cell carcinoma of the oropharynx. Anticancer Res 2010;30:2291-6.
39. Tao L, Lefevre M, Ricci S, Saintigny P, Callard P, Perie S, et al. Detection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA. Br J Cancer 2006;94:1164-9.
40. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007;104:973-8.
41. Major AG, Pitty LP, Farah CS. Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int 2013;2013:319489.
42. Pitiyage G, Lei M, Guererro Urbano T, Odell E, Thavaraj S. Biphenotypic human papillomavirus-associated head and neck squamous cell carcinoma: a report of two cases. Diagn Pathol 2015;10:97.
43. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002;102:152-8.
44. Van Tine BA, Dao LD,WuSY, Sonbuchner TM, Lin BY, Zou N, et al. Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc Natl Acad Sci U S A 2004;101:4030-5.
45. Slebos RJ, Jehmlich N, Brown B, Yin Z, Chung CH, Yarbrough WG, et al. Proteomic analysis of oropharyngeal carcinomas reveals novel HPV-associated biological pathways. Int J Cancer 2013;132:568-79.
46. Sepiashvili L, Waggott D, Hui A, ShiW, Su S, Ignatchenko A, et al. Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway. Mol Cell Proteomics 2014;13:3572-84.
47. Descamps G, Wattiez R, Saussez S. Proteomic study of HPV-positive head and neck cancers: preliminary results. Biomed Res Int 2014;2014:430906.
48. Frandsen VL, Larsen CG, von Buchwald C. Prevalence of human papillomavirus in squamous cell carcinomas of the soft palate. J Clin Pathol 2015;68:942-3.
49. Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsague X, Laporte L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 2014;15: 1319-31.
50. Chaturvedi A, Gillison M. Human papillomavirus and head and neck cancer. In: Olshan A, editor. Epidemiology, pathogenesis, and prevention of head and neck cancer. New York, NY: Springer; 2010. p. 96.
51. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95: 1772-83.
52. Colevas AD. Population-based evaluation of incidence trends in oropharyngeal cancer focusing on socioeconomic status, sex, and race/ethnicity. Head Neck 2014;36:34-42.
53. Yang EJ, Quick MC, Hanamornroongruang S, Lai K, Doyle LA, McKeon FD, et al. Microanatomy of the cervical and anorectal squamocolumnar junctions: a proposed model for anatomical differences in HPV-related cancer risk. Mod Pathol 2015;28:994-1000.
54. Herfs M, Somja J, Howitt BE, Suarez-Carmona M, Kustermans G, Hubert P, et al. Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction. Int J Cancer 2015;136: 1043-52.
55. Fakhry C, Andersen KK, Christensen J, Agrawal N, Eisele DW. The impact of tonsillectomy upon the risk of oropharyngeal carcinoma diagnosis and prognosis in the Danish Cancer Registry. Cancer Prev Res (Phila) 2015;8:583-9.
56. Chaturvedi AK, Song H, Rosenberg PS, Ramqvist T, Anderson WF, Munck-Wikland E, et al. Tonsillectomy and incidence of oropharyngeal cancers. Cancer Epidemiol Biomarkers Prev 2016;25:944-50.
57. Misiukiewicz K, Posner M. Role of prophylactic bilateral tonsillectomy as a cancer preventive strategy. Cancer Prev Res (Phila) 2015;8:580-2.
58. Oue N, Noguchi T, Anami K, Kitano S, Sakamoto N, Sentani K, et al. Cytokeratin 7 is a predictivemarker for survival in patientswith esophageal squamous cell carcinoma. Ann Surg Oncol 2012;19:1902-10.
59. Yamada A, Sasaki H, Aoyagi K, SanoM, Fujii S, Daiko H, et al. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus. Oncol Rep 2008;20:1021-7.
60. Yun SP, Seo HI. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer. BMC Gastroenterol 2015;15:165.
61. Goldenberg D, Sciubba J, Koch WM. Cysticmetastasis from head and neck squamous cell cancer: a distinct disease variant? Head Neck 2006;28: 633-8.
62. Yasui T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, et al. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS One 2014;9: e95364.
63. McHugh JB. Association of cystic neck metastases and human papillomavirus-positive oropharyngeal squamous cell carcinoma. Arch Pathol Lab Med 2009;133:1798-803.
64. Goldenberg D, Begum S,Westra WH, Khan Z, Sciubba J, Pai SI, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPVassociated phenomenon. Head Neck 2008;30:898-903.
65. Mokhtari S. Mechanisms of cyst formation in metastatic lymph nodes of head and neck squamous cell carcinoma. Diagn Pathol 2012;7:6.
66. Regauer S, Beham A, Mannweiler S. CK7 expression in carcinomas of the Waldeyer's ring area. Hum Pathol 2000;31:1096-101.
67. Regauer S, Mannweiler S, Anderhuber W, Gotschuli A, Berghold A, Schachenreiter J, et al. Cystic lymph node metastases of squamous cell carcinoma of Waldeyer's ring origin. Br J Cancer 1999;79:1437-42.
68. Smith FJ, Porter RM, Corden LD, Lunny DP, Lane EB, McLean WH. Cloning of human, murine, and marsupial keratin 7 and a survey of K7 expression in the mouse. Biochem Biophys Res Commun 2002;297:818-27.